Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathologic Effects of Neoadjuvant Radiation Therapy in Operable Early Stage Lung Cancer

NCT01138722 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01138722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01138722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathologic Effects of Neoadjuvant Radiation Therapy in Operable Early Stage Lung Cancer
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2010
Completion date
August 31, 2011
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

early stage non-small cell lung cancer